What is QHSLab Inc's earnings per share (EPS)?

QHSLab Inc (USAQ) reported diluted earnings per share of $0.02 for fiscal year 2025. This represents a 166.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

QHSLab Inc Financials

USAQ

Trailing 12 months to June 30, 2026

Revenue $3.0M +24.6% YoY

Net Income -$391K -5.5% YoY

EPS (Diluted) $0.03 +175.0% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 12, 2026 Currency USD FYE December

QHSLab Inc (USAQ) reported $3.0M in revenue over the twelve months to Jun 30, 2026, up 24.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI USAQ FY2025 2026-08-30

Gross-margin expansion has not yet translated into durable operating cash generation or net profitability.

Gross margin expanded materially across FY2023-FY2025, and operating income turned positive in FY2024. Yet operating cash flow swung from $142K in FY2024 to -$178K in FY2025 even as operating income stayed positive, indicating that reported operating profitability did not convert cleanly into cash.

The 2025 balance sheet is structurally different: total liabilities fell from $2.4M in FY2024 to $546K, reversing the prior negative-equity posture. Current ratio rose to 2.0x, so short-term obligations were no longer larger than current assets at year-end.

That repair coincided with $301K of financing cash flow and a 33.3% increase in shares outstanding, linking stronger capitalization to external funding rather than internally generated cash. Meanwhile, SG&A and R&D rose in FY2025 while operating margin narrowed to 4.9%, suggesting gross-margin gains were partly absorbed by overhead and development investment.

Financial Health Signals

Financial health score not available

QHSLab Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Safe

4.42

QHSLab Inc scores 4.42, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($4.8M) relative to total liabilities ($546K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

QHSLab Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

QHSLab Inc reported a net loss of $457K while operations used $178K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.55x

QHSLab Inc earns $0.55 in operating income for every $1 of interest expense ($131K vs $237K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.7M

YoY+26.3%

5Y CAGR+84.9%

QHSLab Inc generated $2.7M in revenue in fiscal year 2025. This represents an increase of 26.3% from the prior year.

EBITDA

$222K

YoY-37.0%

QHSLab Inc's EBITDA was $222K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 37.0% from the prior year.

Net Income

-$457K

YoY-76.4%

QHSLab Inc reported -$457K in net income in fiscal year 2025. This represents a decrease of 76.4% from the prior year.

EPS (Diluted)

$0.02

YoY+166.7%

QHSLab Inc earned $0.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 166.7% from the prior year.

Cash & Balance Sheet

Cash & Debt

$636K

YoY+304.8%

5Y CAGR+46.5%

QHSLab Inc held $636K in cash against $91K in long-term debt as of fiscal year 2025.

Shares Outstanding

15M

YoY+33.3%

5Y CAGR+17.1%

10Y CAGR+9.6%

QHSLab Inc had 15M shares outstanding in fiscal year 2025. This represents an increase of 33.3% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

67.3%

YoY+3.6pp

5Y CAGR+27.0pp

QHSLab Inc's gross margin was 67.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3.6 percentage points from the prior year.

Operating Margin

4.9%

YoY-4.8pp

QHSLab Inc's operating margin was 4.9% in fiscal year 2025, reflecting core business profitability. This is down 4.8 percentage points from the prior year.

Net Margin

-17.0%

YoY-4.8pp

QHSLab Inc's net profit margin was -17.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.8 percentage points from the prior year.

Return on Equity

-28.1%

QHSLab Inc's ROE was -28.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

$485K

YoY+64.7%

5Y CAGR+37.6%

QHSLab Inc invested $485K in research and development in fiscal year 2025. This represents an increase of 64.7% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

USAQ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

USAQ quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$3.0M	$2.7M+26.3%	$2.1M+51.3%	$1.4M+13.3%	$1.2M-12.1%	$1.4M+1035.8%	$125K	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0
Cost of Revenue	$975K	$881K+13.8%	$774K+25.8%	$615K-1.3%	$624K-16.1%	$744K+899.0%	$74K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$2.0M	$1.8M+33.4%	$1.4M+71.1%	$794K+28.1%	$620K-7.6%	$671K+1239.0%	$50K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$484K	$485K+64.7%	$294K+37.6%	$214K+12.6%	$190K+109.2%	$91K-7.5%	$98K-1.9%	$100K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$597K	$439K+58.8%	$276K+6.7%	$259K-33.1%	$388K-14.6%	$454K+244.6%	$132K+144.6%	$54K	N/A	$105-99.1%	$12K-68.6%	$38K+31.9%	$29K-52.4%	$61K+0.4%	$61K-10.9%	$68K
Operating Income	$83K	$131K-36.2%	$206K+185.7%	-$240K+57.2%	-$561K-11.6%	-$502K-82.6%	-$275K	N/A	N/A	-$105+99.5%	-$23K+96.8%	-$722K	N/A	N/A	N/A	N/A
Interest Expense	$122K	$237K-48.9%	$465K+101.8%	$230K-46.8%	$433K+75.8%	$246K+695.5%	$31K+149.5%	$12K	N/A	$11K-0.3%	$11K-1.7%	$11K-0.7%	$12K+26.6%	$9K0.0%	$9K0.0%	$9K
Income Tax	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$391K	-$457K-76.4%	-$259K+44.6%	-$468K+53.0%	-$996K-29.3%	-$770K-135.2%	-$327K	N/A	N/A	-$11K+51.2%	-$23K+96.8%	-$722K-1684.1%	-$40K+42.1%	-$70K-0.4%	-$70K+9.6%	-$77K
EPS (Diluted)	$0.03	$0.02+166.7%	-$0.03+40.0%	-$0.05+54.5%	-$0.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$847K+16.3%	$729K+3.5%	$704K-4.5%	$737K+21.7%	$605K-6.2%	$645K+3.1%	$626K+15.0%	$544K
Cost of Revenue	$258K-0.1%	$258K+19.6%	$216K-11.5%	$243K+17.9%	$206K-4.2%	$215K+0.8%	$214K+19.4%	$179K
Gross Profit	$590K+25.3%	$471K-3.6%	$488K-1.1%	$494K+23.7%	$399K-7.2%	$430K+4.3%	$412K+12.9%	$365K
R&D Expenses	$115K-5.2%	$121K+4.5%	$116K-12.9%	$133K+18.2%	$112K-9.4%	$124K+15.3%	$108K+35.3%	$80K
SG&A Expenses	$255K+22.9%	$208K+197.8%	$70K+9.0%	$64K-57.3%	$150K-3.7%	$156K+86.5%	$83K+49.7%	$56K
Operating Income	$45K+147.9%	-$94K-365.8%	$36K-63.1%	$96K+735.1%	$12K+195.7%	-$12K-116.5%	$73K-18.0%	$89K
Interest Expense	$7K-24.3%	$10K-77.6%	$43K-32.3%	$63K-2.5%	$64K-4.6%	$68K-81.3%	$361K+817.3%	$39K
Net Income	$38K+136.6%	-$104K+71.0%	-$358K-1172.3%	$33K+163.1%	-$53K+33.5%	-$80K+72.3%	-$288K-677.9%	$50K
EPS (Diluted)	$0.00	$0.00-100.0%	$0.03	$0.00	$0.00+100.0%	-$0.01+66.7%	-$0.03	$0.00

Not reported in any period shown, so not listed: Income Tax.

USAQ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

USAQ quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$2.2M+20.6%	$1.8M+7.0%	$1.7M-14.1%	$2.0M-11.4%	$2.2M+641.4%	$298K+1030.8%	$26K+1405.1%	$2K	$0	$0	$0	$0	$0	$0	$0
Current Assets	$883K+109.8%	$421K+169.5%	$156K-45.3%	$286K-35.9%	$446K+67.5%	$266K+910.5%	$26K	N/A	N/A	N/A	$0	$0	$0	$0	$0
Cash & Equivalents	$636K+304.8%	$157K+204.7%	$52K-71.1%	$179K-37.7%	$287K+204.1%	$94K+299.9%	$24K	$0	N/A	N/A	$0	$0	$0	$0	$0
Inventory	$36K-14.3%	$42K+65.9%	$25K-51.4%	$52K-21.1%	$66K-34.1%	$100K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$191K-2.8%	$196K+174.7%	$71K+49.5%	$48K-32.3%	$70K+16.4%	$61K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$546K-77.3%	$2.4M+17.0%	$2.1M+9.3%	$1.9M+35.9%	$1.4M+52.8%	$906K+98.7%	$456K-14.8%	$535K+8.2%	$495K+2.3%	$484K+5.1%	$460K+11.4%	$413K+10.9%	$373K+23.1%	$303K+29.9%	$233K
Current Liabilities	$450K-81.3%	$2.4M+17.0%	$2.1M+20.5%	$1.7M+95.1%	$875K+307.7%	$215K+924.8%	$21K-89.8%	$206K+24.4%	$166K+7.4%	$154K+17.7%	$131K-68.3%	$413K+10.9%	$373K+23.1%	$303K+29.9%	$233K
Long-Term Debt	$91K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$329K	N/A	N/A	N/A	N/A
Total Equity	$1.6M+367.4%	-$608K-61.8%	-$376K-592.6%	$76K-90.7%	$824K+235.5%	-$608K-41.5%	-$430K+19.4%	-$534K-7.8%	-$495K-2.3%	-$484K-5.1%	-$460K-11.4%	-$413K-10.9%	-$373K-23.1%	-$303K-29.9%	-$233K
Retained Earnings	-$3.9M+9.9%	-$4.3M-8.7%	-$4.0M-13.3%	-$3.5M-39.5%	-$2.5M-44.0%	-$1.7M-23.0%	-$1.4M-13.3%	-$1.3M-3.2%	-$1.2M-0.9%	-$1.2M-2.0%	-$1.2M-157.2%	-$459K-9.7%	-$419K-20.0%	-$349K-24.9%	-$280K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.9M+2.4%	$1.9M-13.0%	$2.2M+25.2%	$1.7M+1.4%	$1.7M+2.5%	$1.7M-7.3%	$1.8M+2.0%	$1.8M
Current Assets	$683K+10.3%	$619K-29.9%	$883K+106.0%	$429K+11.0%	$386K+18.5%	$326K-22.6%	$421K+20.5%	$349K
Cash & Equivalents	$317K-12.3%	$362K-43.1%	$636K+301.6%	$158K-5.9%	$168K+175.7%	$61K-61.1%	$157K+63.8%	$96K
Inventory	$9K-68.0%	$28K-23.1%	$36K+34.5%	$27K-37.0%	$42K+44.8%	$29K-30.1%	$42K+4.4%	$40K
Accounts Receivable	$343K+70.4%	$201K+5.6%	$191K-9.3%	$210K+41.8%	$148K-24.0%	$195K-0.6%	$196K-1.1%	$198K
Total Liabilities	$376K+2.1%	$368K-32.6%	$546K-76.7%	$2.3M-0.4%	$2.4M+4.2%	$2.3M-6.1%	$2.4M+14.6%	$2.1M
Current Liabilities	$376K+2.1%	$368K-18.2%	$450K-80.8%	$2.3M-0.4%	$2.4M+4.2%	$2.3M-6.1%	$2.4M+15.2%	$2.1M
Long-Term Debt	N/A	$37K-59.3%	$91K	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.6M+2.5%	$1.5M-6.4%	$1.6M+366.0%	-$611K+5.2%	-$644K-9.0%	-$591K+2.7%	-$608K-81.3%	-$335K
Retained Earnings	-$4.0M+0.9%	-$4.0M-2.7%	-$3.9M+11.9%	-$4.4M+0.7%	-$4.5M-1.2%	-$4.4M-1.8%	-$4.3M-7.9%	-$4.0M

Not reported in any period shown, so not listed: Goodwill.

USAQ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

USAQ quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$464K	-$178K-225.1%	$142K+189.2%	-$160K+54.5%	-$351K+1.1%	-$355K-114.3%	-$166K	N/A	N/A	-$105+99.2%	-$14K+63.4%	-$38K-107.0%	-$18K-52.3%	-$12K-382.7%	-$3K+16.7%	-$3K
Investing Cash Flow	N/A	N/A	N/A	N/A	-$37K+76.0%	-$155K-387.6%	-$32K	N/A	N/A	N/A	N/A	N/A	$0	$0	$0	$0
Financing Cash Flow	$256K	$301K+916.5%	-$37K-213.3%	$33K-88.4%	$280K-60.1%	$702K+161.9%	$268K	N/A	N/A	$105-99.2%	$14K-63.4%	$38K+107.0%	$18K+52.3%	$12K+382.7%	$3K-16.7%	$3K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$8K+96.1%	-$200K+22.4%	-$258K-10027.1%	$3K-98.0%	$127K+356.4%	-$50K-190.0%	$55K+197.3%	-$57K
Financing Cash Flow	-$37K+50.0%	-$74K-119.4%	$380K+3121.4%	-$13K+36.3%	-$20K+57.6%	-$47K-854.2%	$6K-87.2%	$48K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

USAQ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

USAQ quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	67.3%+3.6pp	63.7%+7.4pp	56.3%+6.5pp	49.8%+2.4pp	47.4%+7.2pp	40.2%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	4.9%-4.8pp	9.7%+26.7pp	-17.0%+28.1pp	-45.1%-9.6pp	-35.5%	-220.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-17.0%-4.8pp	-12.2%+21.1pp	-33.2%+46.9pp	-80.1%-25.7pp	-54.4%	-262.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-28.1%	N/A	N/A	-1306.3%-1212.9pp	-93.5%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-21.1%-6.7pp	-14.4%+13.4pp	-27.9%+23.0pp	-50.9%-16.0pp	-34.9%+75.0pp	-109.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.96+1.8x	0.17+0.1x	0.08-0.1x	0.17-0.3x	0.51-0.7x	1.240.0x	1.26	N/A	N/A	N/A	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.00
Debt-to-Equity	0.06	N/A	N/A	24.67+23.0x	1.68	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	69.6%+5.0pp	64.6%-4.8pp	69.4%+2.4pp	67.0%+1.1pp	65.9%-0.7pp	66.6%+0.8pp	65.8%-1.2pp	67.1%
Operating Margin	5.3%+18.3pp	-13.0%-18.0pp	5.0%-8.0pp	13.1%+11.2pp	1.9%+3.8pp	-1.9%-13.5pp	11.7%-4.7pp	16.4%
Net Margin	4.5%+18.8pp	-14.3%+36.6pp	-50.9%-55.4pp	4.5%+13.3pp	-8.8%+3.6pp	-12.3%+33.6pp	-45.9%-55.1pp	9.1%
Return on Equity	2.4%+9.3pp	-6.8%+15.2pp	-22.0%	N/A	N/A	N/A	N/A	N/A
Return on Assets	2.0%+7.5pp	-5.5%+11.0pp	-16.5%-18.4pp	1.9%+5.0pp	-3.1%+1.7pp	-4.8%+11.2pp	-16.0%-18.8pp	2.8%
Current Ratio	1.82+0.1x	1.68-0.3x	1.96+1.8x	0.180.0x	0.160.0x	0.140.0x	0.170.0x	0.17
Debt-to-Equity	0.24+0.2x	0.020.0x	0.06	N/A	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Ir-Med Inc IRME

$231K

Therma Bright Inc TBRIF

$2.4M

Bionoid Pharma Inc BINP

$1.6M

Cyduct Diagnostics Inc CYDX

$3.3M

Kelyniam Global Inc KLYG

$6.6M

Where QHSLab Inc Ranks

Frequently Asked Questions

What is QHSLab Inc's annual revenue?

QHSLab Inc (USAQ) reported $2.7M in total revenue for fiscal year 2025. This represents a 26.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is QHSLab Inc's revenue growing?

QHSLab Inc (USAQ) revenue grew by 26.3% year-over-year, from $2.1M to $2.7M in fiscal year 2025.

Is QHSLab Inc profitable?

No, QHSLab Inc (USAQ) reported a net income of -$457K in fiscal year 2025, with a net profit margin of -17.0%.

What is QHSLab Inc's EBITDA?

QHSLab Inc (USAQ) had EBITDA of $222K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does QHSLab Inc have?

As of fiscal year 2025, QHSLab Inc (USAQ) had $636K in cash and equivalents against $91K in long-term debt.

What is QHSLab Inc's gross margin?

QHSLab Inc (USAQ) had a gross margin of 67.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is QHSLab Inc's operating margin?

QHSLab Inc (USAQ) had an operating margin of 4.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is QHSLab Inc's net profit margin?

QHSLab Inc (USAQ) had a net profit margin of -17.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is QHSLab Inc's return on equity (ROE)?

QHSLab Inc (USAQ) has a return on equity of -28.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is QHSLab Inc's operating cash flow?

QHSLab Inc (USAQ) recorded an outflow of $178K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are QHSLab Inc's total assets?

QHSLab Inc (USAQ) had $2.2M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does QHSLab Inc spend on research and development?

QHSLab Inc (USAQ) invested $485K in research and development during fiscal year 2025.

How many shares does QHSLab Inc have outstanding?

QHSLab Inc (USAQ) had 15M shares outstanding as of fiscal year 2025.

What is QHSLab Inc's current ratio?

QHSLab Inc (USAQ) had a current ratio of 1.96 as of fiscal year 2025, which is generally considered healthy.

What is QHSLab Inc's debt-to-equity ratio?

QHSLab Inc (USAQ) had a debt-to-equity ratio of 0.06 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is QHSLab Inc's return on assets (ROA)?

QHSLab Inc (USAQ) had a return on assets of -21.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does QHSLab Inc's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, QHSLab Inc (USAQ) held $636K in cash, cash equivalents and investments, and reported an operating cash outflow of $178K over that year. Dividing the one by the other, the reported balance equals about 43 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is QHSLab Inc's Altman Z-Score?

QHSLab Inc (USAQ) has an Altman Z-Score of 4.42, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is QHSLab Inc's Piotroski F-Score?

QHSLab Inc (USAQ) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are QHSLab Inc's earnings high quality?

QHSLab Inc (USAQ) reported a net loss of $457K while operations used $178K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can QHSLab Inc cover its interest payments?

QHSLab Inc (USAQ) has an interest coverage ratio of 0.55x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.